skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

97 Total results for product and free and sample content found

Pharma Intelligence Apps

What Does The Pharma Industry Want From CDMOs?

13 May 2022

Pharma Intelligence

Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.

Topic Business Strategies Leadership

Biomedtracker, Meddevicetracker

Don’t miss your free extract of Early 2022 Outlook Report

08 Feb 2022

Don’t miss your free extract of Early 2022 Outlook Report

In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

Topic Business Strategies

TrialScope Disclose

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

11 Jan 2022

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.

Topic Business Strategies Clinical Trials

Pink Sheet

Download your free accelerated trials article pack for insights into the latest developments

07 Dec 2021

Download your free accelerated trials article pack for insights into the latest developments

Don’t miss updates on recent news in accelerated trials and its implications for drug development in the United States.

Topic Business Strategies

Scrip

Scrip Asia 100

20 Sep 2021

Scrip Asia 100

The highly anticipated Scrip Asia 100 is back, and there are a limited number of opportunities for you to be a part of it. Don’t miss your chance to connect to APAC market leaders with a high-profile sponsorship of this essential annual financial performance ranking of pharma companies headquartered in the APAC region.

Topic Business Strategies

Scrip

Scrip Asia 100 Report Extract

26 Mar 2021

Scrip_Asia_100_Content_Tile

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence

Trialtrove

2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts

27 Nov 2020

2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts

See last year’s clinical trial activity through the eyes of our expert analysts and get a better sense of where the industry is headed. This new whitepaper is the annual analysis of Phase I-III clinical trials, from Citeline’s Trialtrove, and reveals the priorities and strategies of the biopharma industry.  

Topic Drug Development Landscape BioPharmaceutical Business Strategies

Scrip

Operation Warp Speed Spreads Its Bets With $1.6bn Novavax Deal

By Andrew McConaghie 10 Jul 2020

operation-warp-speed

Novavax has progressed into Phase I trials with relatively little funding, but backing from Operation Warp Speed makes it a stronger contender.

Topic Coronavirus Business Strategies

Scrip

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

By Andy Smith 30 Jan 2020

Stockwatch_Earnings_Season_Catches_An_Early_Cold

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

Topic Business Strategies Coronavirus Sales Earnings Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: